Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-349-5730
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2009 - 2012
- Perelman School of Medicine at the University of PennsylvaniaClass of 2009
Certifications & Licensure
- PA State Medical License 2009 - 2024
- NY State Medical License 2012 - 2015
Clinical Trials
- MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2018 Oct 24
- Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC Start of enrollment: 2020 Jul 20
Roles: Contact, Principal Investigator
- Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer Start of enrollment: 2021 Jul 21
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsClinical management of TP53 mosaic variants found on germline genetic testing.Abigail Ward, Dana Farengo-Clark, Danielle B McKenna, Anton Safonov, Madeline Good
Cancer Genetics. 2024-06-01 - Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on,, and Lynch Syndrome.Charles M Bowen, Kaitlin Demarest, Eduardo Vilar, Payal D Shah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - 2 citationsEpithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, Ann Hanna, Brandie C Taylor
Cancer Research Communications. 2024-04-24
Press Mentions
- A Brighter Outlook for Metastatic Breast CancerNovember 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: